Universal Biologicals (Cambridge) Limited Filleted accounts for Companies House (small and micro)

COMPANY REGISTRATION NUMBER: 01497118

Universal Biologicals (Cambridge) Limited

Unaudited financial statements

31 December 2025

Universal Biologicals (Cambridge) Limited

Statement of financial position

31 December 2025

	2025		2024
Note	£	£	£	£

Fixed assets

Tangible assets	5	1,219	3,015
Investments	6	100	–
		------	------
		1,319	3,015

Current assets

Stocks		42,431	55,828
Debtors	7	103,499	110,218
Cash at bank and in hand		77,445	76,022
		---------	---------
		223,375	242,068

Creditors: Amounts falling due within one year	8	( 72,233)		( 116,018)
		---------		---------
Net current assets			151,142		126,050
			---------		---------
Total assets less current liabilities			152,461		129,065

Provisions

Taxation including deferred tax	( 305)	( 754)
	---------	---------
Net assets	152,156	128,311
	---------	---------

Capital and reserves

Called up share capital	100	100
Profit and loss account	152,056	128,211
	---------	---------
Shareholders funds	152,156	128,311
	---------	---------

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.

For the year ending 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;

- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .

Universal Biologicals (Cambridge) Limited

Statement of financial position (continued)

31 December 2025

These financial statements were approved by the board of directors and authorised for issue on 22 June 2026 , and are signed on behalf of the board by:

E S Liddle

Director

Company registration number: 01497118

Universal Biologicals (Cambridge) Limited

Notes to the financial statements

Year ended 31 December 2025

1. General information

The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Passhouse Farmhouse, Papworth St Agnes, Cambridge, CB23 3QU.

2. Statement of compliance

These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.

3. Accounting policies

Basis of preparation

The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.

The financial statements are prepared in sterling, which is the functional currency of the entity.

Revenue recognition

Turnover is recognised at the fair value of the consideration received or receivable in the ordinary course of business, and is shown net of Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.

Income tax

Provision is made, under the liability method, to take account of timing differences between the treatment of certain items for accounts purposes and their treatment for tax purposes. Tax deferred or accelerated is accounted for in respect of all material timing differences. Deferred tax assets are recognised only to the extent that the directors consider that it is more likely than not that there will be suitable taxable profits from which the future reversal of the underlying timing differences can be deducted.

Foreign currencies

Foreign currency transactions are initially recorded in the functional currency, by applying the spot exchange rate as at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are translated at the exchange rate ruling at the reporting date, with any gains or losses being taken to the profit and loss account.

Tangible assets

Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in equity, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation, is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in equity in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in equity in respect of that asset, the excess shall be recognised in profit or loss.

Depreciation

Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:

Plant and machinery	-	20% reducing balance
Fixtures and fittings	-	20% reducing balance
Computer equipment	-	25% reducing balance
Website	-	20% straight line

Investments

Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses.

Listed investments are measured at fair value with changes in fair value being recognised in profit or loss.

Stocks

Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all costs of purchase, costs of conversion and other costs incurred in bringing the stock to its present location and condition.

4. Employee numbers

The average number of employees during the year was 3 (2024: 3 ).

5. Tangible assets

	Plant and machinery	Fixtures and fittings	Computer equipment	Website	Total
	£	£	£	£	£
Cost
At 1 January 2025 and 31 December 2025	2,777	14,370	9,270	74,838	101,255
	------	-------	------	-------	---------
Depreciation
At 1 January 2025	2,691	14,142	6,569	74,838	98,240
Charge for the year	86	94	1,616	–	1,796
	------	-------	------	-------	---------
At 31 December 2025	2,777	14,236	8,185	74,838	100,036
	------	-------	------	-------	---------
Carrying amount
At 31 December 2025	–	134	1,085	–	1,219
	------	-------	------	-------	---------
At 31 December 2024	86	228	2,701	–	3,015
	------	-------	------	-------	---------

6. Investments

	Shares in group undertakings
	£
Cost
At 1 January 2025 and 31 December 2025	100
	----
Impairment
At 1 January 2025 and 31 December 2025	–
	----

Carrying amount
At 31 December 2025	100
	----
At 31 December 2024	100
	----

7. Debtors

	2025	2024
	£	£
Trade debtors	75,602	100,636
Other debtors	27,897	9,582
	---------	---------
	103,499	110,218
	---------	---------

8. Creditors: Amounts falling due within one year

	2025	2024
	£	£
Trade creditors	4,749	36,228
Social security and other taxes	43,098	46,454
Other creditors	24,386	33,336
	-------	---------
	72,233	116,018
	-------	---------

At the reporting date, the Company had an outstanding balance of £100 due to a group company. The balance is interest-free, unsecured, and repayable on demand.

9. Operating leases

The total future minimum lease payments under non-cancellable operating leases are as follows:

	2025	2024
	£	£
Not later than 1 year	14,867	14,554
Later than 1 year and not later than 5 years	18,409	8,555
	-------	-------
	33,276	23,109
	-------	-------

10. Directors' advances, credits and guarantees

Included within debtors at the year end is an directors loan account of £27,329 (2024: £7,065). The maximum overdrawn balance during the year was £27,329 (2024: £10,463). Interest of £271 (2024: £Nil) was charged at the official rate.